Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.
Prominin-1 (CD133) is a commonly used cancer stem cell marker in central nervous system (CNS) tumors including glioblastoma (GBM). Expression of Prom1 in cancer is thought to parallel expression and function in normal stem cells. Using RNA in situ hybridization and antibody tools capable of detectin...
Main Authors: | Karl Holmberg Olausson, Cecile L Maire, Sam Haidar, Jason Ling, Emily Learner, Monica Nistér, Keith L Ligon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4153667?pdf=render |
Similar Items
-
Prominin 1/CD133 endothelium sustains growth of proneural glioma.
by: Bi-Sen Ding, et al.
Published: (2013-01-01) -
CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.
by: Yirui Sun, et al.
Published: (2009-01-01) -
Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).
by: Kristina Thamm, et al.
Published: (2016-01-01) -
Non-invasive in vivo imaging of tumor-associated CD133/prominin.
by: Chizuko Tsurumi, et al.
Published: (2010-12-01) -
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells.
by: Erika Bourseau-Guilmain, et al.
Published: (2011-01-01)